Opioids, CBD and Nicotine Addiction Recovery

CBD and Nicotine Addiction

Scientists are looking at CBD as a means of nicotine addiction recovery.  However, professionals are just learning about CBD and nicotine addiction.  Many endocannabinoid professionals are not only looking at nicotine addiction, but a wide variety of other contributing factors, as well.

Addictive Behaviors published a study related to CBD and nicotine addiction.  In this study, medical researchers gave patients an inhaler containing a CBD compound. Smokers who were treated with the CBD inhaler smoked fewer cigarettes without any additional craving for nicotine. (https://www.ncbi.nlm.nih.gov/pubmed/23685330)

CBD and Opiate Addiction

Neurotherapeutics posted another study closely related to CBD and nicotine addiction.  Actually, this was a study with a focus on CBD and opiate addiction.  In this study, detox staff were successful in reducing opioid withdrawals with CBD therapy.  Furthermore, patients who received CBD therapy experienced long-term recovery from lethal heroin and narcotic pain killer addictions. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604178/)

In both of these studies, medical professionals reported that CBD treatment helped to alleviate classic withdrawal symptoms.  More specifically, they were able to treat symptoms such as anxiety, insomnia, pain, and shifting moods.

Scientists already know a lot about both CBD and nicotine addiction.  As such, they know that many of the symptoms patients experience during periods of nicotine withdrawal are very similar to those that patients experience when detoxing from opiates.  As a matter of fact, lots of recovering addicts who have successfully quit heroin have not been able to quit nicotine.

CBD and Schizophrenia

Current Pharmaceutical Design reported a study related to CBD and schizophrenia.  In the documentation of this study, scientists noted that CBD could be highly effective in treating Schizophrenia and other psychiatric conditions.  That being the case, scientists can use this knowledge for more effective research on CBD and nicotine addiction recovery.  Correspondingly, nicotine withdrawal symptoms can easily mimic psychosis.

(https://www.ncbi.nlm.nih.gov/pubmed/22716160)

Medial professionals are realizing that CBD may be a suitable alternative to pharmaceutical antipsychotics.  Traditionally, prescription drugs that treat psychosis all come with a long list of negative short-term and long-term side effects.  These side effects range from impaired functionality to retarded ideokinesis (a condition with ticks and twitches associated with long-term antipsychotic treatment). CBD has a series of calming properties.  That being the case, it may be the safest antipsychotic available.  At the current time, scientists believe that optimal treatment levels for CBD as an antispychotic exceed 1,200 mg.

CBD and nicotine addiction are being discussed along with this and other psychiatric conditions.  Scientists are also looking into CBD for relief from other addictive substances, as well. Ultimately, the benefit of CBD and nicotine addiction – along with opiate addiction and treatment for psychiatric conditions –  is:  CBD is not mind-altering.  Therefore, the risk of trading one addiction for another is greatly minimized.  Furthermore, it can help mental health patients to find clarity without the sedating effects of traditional psych medication.  As medical researchers learn more about CBD and nicotine addiction (and conduct other CBD disease research), perhaps more individuals can enjoy recovery.

Leave a Comment

Your email address will not be published. Required fields are marked *